Skip to main content
    M

    Mink Therapeutics Inc (INKT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.29
    -0.07 (-0.70%)

    Market Cap: $47.95M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Mink Therapeutics Inc (INKT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Mink Therapeutics (INKT) has a latest price of $9.29 on Nov 17, 2026, 45.2% below its 52-week high of $16.93. Its price fell 27.2% over the past 12 months. The month-end price fell 94.1% over the 5 years through Oct 2026, a compound annual decline of 43.3%.

    Price Chart

    From Oct 2021 to Oct 2026, its highest month-end close was $178.90 in Oct 2021 and its lowest $6.97 in Dec 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart INKT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INKT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 16.6%, and over 6 months it fell 10.3%. The month-end price rose 3.2% over the 3 years through Oct 2026, a compound annual rate of 1.1%.

    PeriodChange
    1 month-2.9%
    3 months-16.6%
    6 months-10.3%
    12 months-27.2%
    12 months, with dividends-27.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+3.2%+1.1%
    5 years-94.1%-43.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 60.0%, and its weakest was 2023, when it fell 59.0%.

    YearCloseChange
    2026 through Oct 2026$10.53-5.6%
    2025$11.15+60.0%
    2024$6.97-34.9%
    2023$10.70-59.0%
    2022$26.10-41.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 15.7% below its 50-day average of $11.01 and 16.8% below its 200-day average of $11.16.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.29
    52-week high$16.93-45.2%
    52-week low$8.48+9.5%
    50-day average$11.01-15.7%
    200-day average$11.16-16.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 86.7%.

    MeasureValue
    1-year beta0.61
    Largest fall, 1 year-36.6%
    Largest fall, 3 years-86.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About INKT

    What is INKT's 1-year price change?

    Mink Therapeutics's price fell 27.2% over the past 12 months. With dividends included, the 12-month total return was -27.2%.

    What is INKT's 5-year price change?

    Mink Therapeutics's month-end price fell 94.1% over the 5 years through Oct 2026, a compound annual decline of 43.3%. These figures leave out dividends.

    What is INKT's 52-week high and low?

    Mink Therapeutics's 52-week high is $16.93 and its 52-week low is $8.48. Its latest price of $9.29 on Nov 17, 2026 is 45.2% below the high.

    What is INKT's beta?

    Mink Therapeutics's 1-year beta against the S&P 500 is 0.61, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 36.6%.

    Is the INKT chart free?

    Yes. Advanced Charting for INKT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.